GLPwatch
Trials (2139)
Page 3 of 36.
- Effects of RDX-002 on Postprandial Triglycerides in Patients Discontinuing GLP-1 Agonists
- A Study of the Effect of Dulaglutide on How Body Handles Digoxin in Healthy Participants
- Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
- Investigation of Optimal Dosing Conditions for a Long Acting GLP-1 Analogue in Healthy Male Subjects
- Regimen Transition After Short-Term Intensive Insulin Therapy in Type 2 Diabetes
- Research Study Comparing New Tablets of Semaglutide in New Doses, in Healthy People
- Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
- Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- A Study of LY3502970 in Chinese Participants With Obesity or Are Overweight With Weight-related Comorbidities
- Pistachio Intake and Nutrition-Related Outcomes in Individuals on GLP-1 Therapy
- A Study to Measure Calorie Consumption and Usage in Participants With Obesity Using LY3437943
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects
- Efficacy and Long-term Safety of Oral Semaglutide Versus Sitagliptin in Subjects With Type 2 Diabetes
- Effects of GH and Lirglutide on AgRP
- Investigation of Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-6856 in Healthy Participants, Including a Subset of Healthy Japanese Participants
- Lecanemab for Early Onset Familial Alzheimer's Disease
- Multiple Ascending Dose Study of AMG 598 in Adults With Obesity
- Tirzepatide in MetALD
- Dose Ranging Study of the GLP-1 Agonist AVE0010 in Metformin-Treated Subjects With Type 2 Diabetes Mellitus
- A Study of IBI362 in Poorly Controlled Type 2 Diabetes Patients Only Through Diet and Exercise
- A Research Study to See if Two Different Formulations of Oral Semaglutide Are Equally Safe and Effective in Reducing the Blood Sugar Level in Japanese People With Type 2 Diabetes
- Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus
- LEAN Mass Preservation With Resistance Exercise and Protein During Semaglutide/Tirzepatide Therapy
- Impact of Antiglycemic & Immunosuppressive Therapies on NETosis in Diabetes & Kidney Disease (NETs - Neutrophil Traps)
- A Study to Evaluate the Effect of the Experimental GLP-1 Drug PF-07081532 on Blood Levels of Common Birth Control Pills, and Drugs Omeprazole and Midazolam, and Effect of GLP-1 Drug Semaglutide on Midazolam Blood Levels in Healthy Adults With Weight in the Obesity Range
- A Study of IBI362 in Chinese Patients With Type 2 Diabetes
- Efficacy and Safety of Liraglutide in Combination With Metformin Compared to Metformin Alone, in Children and Adolescents With Type 2 Diabetes
- The Effect of Exercise and Tirzepatide on Weight and Health Outcomes (EXER-MED)
- A Research Study to See How Semaglutide Helps People With Excess Weight, Lose Weight (STEP UP)
- Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection
- Dose-Finding Study Evaluating Effect on Body Composition of Enobosarm in Patients Taking a GLP-1 for Chronic Weight Mgmt
- A Trial Comparing the Efficacy and Safety of Liraglutide 1.8 mg/Day to Liraglutide 0.9 mg/Day in Japanese Subjects With Type 2 Diabetes Mellitus.
- Semaglutide Delivered Epi-Intradermally by Microarray Patch (VX-201) Versus Subcutaneous Administration in Healthy Overweight and Obese Participants
- Acute Metabolic Effects of Tirzepatide in Type 1 Diabetes
- A Study of LY3457263 in Healthy Participants and Participants With Type 2 Diabetes
- A Research Study Looking at How Semaglutide Works in People With Type 2 Diabetes in Canada, as Part of Local Clinical Practice
- A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes Mellitus
- A Research Trial Looking at the Comparability of 2 Different Concentrations of Semaglutide for the 0.5 Milligram (mg) Dose
- Risk of Hypoglycemia in the Transition From Inpatient to Outpatient Setting. Comparative Study of Basal-bolus Insulin Versus Basal Insulin Plus GLP-1 Analogue
- Low Dose Liraglutide and Metformin vs. High Dose Liraglutide Alone in Treatment of Obesity
- A Study of CS060380 Tablets in Patients With MASH and Obesity
- A Research Study Comparing Active Drug in the Blood in Healthy Participants Following Dosing of the Current and a New Formulation (C) Semaglutide Tablets
- GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
- A Clinical Trial Comparing Semaglutide in Healthy People Who Eat and Take the Medicine at Different Times
- Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes
- Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type 2 Diabetes
- Safety, Tolerability and Efficacy of Semaglutide Depot in Subjects With Type-2 Diabetes Mellitus
- DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists
- Comparison of the Effect of Exenatide Versus Sitagliptin on 24-hour Average Glucose in Patients With Type 2 Diabetes on Metformin or a Thiazolidinedione
- Impact of Exenatide on Sleep Duration
- Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
- The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.
- The Microvascular Function of GLP-1 and Its Analogues
- Effect of Aqueous Extracts of Cissus Quadrangularis and Dichrostachys Glomerata on GLP-1 Concentration and DPP-4 Activity in Overweight and Obese Adults
- Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- A Research Study on How Semaglutide Works in People With Fatty Liver Disease and Liver Damage
- Research Study of How Well Semaglutide Works in People Living With Overweight or Obesity.
- A Study of LY3305677 in Participants With Type 2 Diabetes
- Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus